News Daily News Large Registry Study Suggests Amplatzer Plug Cuts Stroke, Bleeding Risks in A-fib Todd Neale February 17, 2015
News Daily News Registry Data Suggest Protection Up to 2 Years With LAA Closure Caitlin E. Cox January 28, 2015
News Daily News Los Datos de Registro Sugieren Protección Hasta 2 Años con el Cierre del AAI Caitlin E. Cox January 28, 2015
News Daily News Hospital Volume Linked to More Favorable LAA Closure Outcomes Todd Neale December 11, 2014
News Daily News PROTECT AF at 4 Years: LAA Closure Maintains Efficacy Over Warfarin Caitlin E. Cox November 19, 2014
News Daily News LAA Closure With Amplatzer Appears Safe, Effective in A-fib Patients Yael L. Maxwell November 06, 2014
News Daily News El Cierre del AAI con Amplatzer parece Seguro y Eficaz en Pacientes con FA Yael L. Maxwell November 06, 2014
News Daily News Preexisting—But Not New-Onset—A-fib Predicts Worse Long-term Outcomes After TAVR October 17, 2014
News Daily News La FA Preexistente, No de Reciente Aparición, Predice Peores Resultados a Largo Plazo Post-TAVR October 17, 2014
News Daily News Time May Be Running Out for Watchman Amid Weak Support From FDA Panel L.A. McKeown October 16, 2014
News Features Thoughtful Insights at TCT: Uncertainty Surrounds Antithrombotic Therapy in PCI Patients Who Require Anticoagulation Todd Neale October 10, 2014
News Conference News TCT 2014 Thoughtful Insights at TCT: Uncertainty Surrounds Antithrombotic Therapy in PCI Patients Who Require Anticoagulation Todd Neale October 10, 2014
News Industry News FDA Advisory Committee Panel Votes In Favor Of The WATCHMAN™ Left Atrial Appendage Closure Device October 08, 2014
Presentation TCT 2014 TCT 175: Preclinical Study of the Novel Generation of Watchman for Left Atrial Appendage Occlusion Presenter: Josep Rodés-Cabau, Peter B Sick, Krzysztof Bartus, Dongming Hou September 16, 2014
Presentation TCT 2014 Watchman Step-by-Step Presenter: Saibal Kar, Horst Sievert, Jochen Wöhrle September 16, 2014
Presentation TCT 2014 TCT 176: Comparison of Imputed Placebo Versus Observed Ischemic Stroke Rates in the Watchman Trials Shows a Significant Reduction in Risk Presenter: John M. Lasala, Stuart J. Pocock, George Hanzel, MD September 16, 2014